Mindfulness-Based Cancer Recovery (MBCR) training: the efficacy on fatigue and sleep quality of Iranian female patients with cancer.
Study Goal
The researchers aimed to examine the efficacy of Mindfulness-Based Cancer Recovery (MBCR) training on fatigue and sleep quality in Iranian female cancer patients.
Results Summary
MBCR significantly improved fatigue levels compared to the control group but had no significant effect on sleep quality. The findings suggest MBCR may be effective for fatigue reduction in this population.
Population
Iranian female patients with cancer
Effective Dosage
8 sessions of MBCR training
Duration
Not explicitly stated (implied by 8 sessions)
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Mindfulness-Based Cancer Recovery (MBCR) training | decrease | level of fatigue | Iranian female patients with cancer | - | significant improvement | #1 |
Mindfulness-Based Cancer Recovery (MBCR) training | no change | level of sleep quality | Iranian female patients with cancer | - | no significant effect | #2 |
OBJECTIVE: The present study aimed to examine the efficacy of Mindfulness-Based Cancer Recovery (MBCR) training on fatigue and sleep quality of Iranian female patients with cancer. METHOD: Thirty female patients with cancer were randomized to one of the MBCR and control groups. Subjects of the MBCR group received 8 sessions of MBCR training, while subjects of the control group received a 1-day didactic stress management seminar (SMS). All participants responded to the Cancer Fatigue Scale (CFT) and the Pittsburgh Sleep Quality Scale (PSQL) as pre- and post-test measures. RESULTS: Using MANCOVA for analyzing data revealed a significant improvement in the level of fatigue among subjects of the MBCR group compared to the controls; however, MBCR had no significant effect on the level of sleep quality. CONCLUSION: The Mindfulness-Based Cancer Recovery program can be considered an effective approach to reducing fatigue for Iranian female patients with cancer. The clinical implications of this finding require further investigation. TRIAL REGISTRATION: The study was registered with the Iranian Registry of Clinical Trials (IRCT) on 24 June 2024; see [IRCT20240315061296N1].